New Rectal Cancer Research from National University Cancer Institute Discussed [Total neoadjuvant therapy (TNT) for locally advanced rectal cancer (LARC): Real-world experience from a tertiary Asian cancer center].
In: Gastroenterology Week, 2024-02-05, S. 688-688
serialPeriodical
Zugriff:
A study conducted at the National University Cancer Institute in Singapore examined the use of total neoadjuvant therapy (TNT) for locally advanced rectal cancer (LARC). The study found that TNT, which combines chemotherapy and radiation before surgery, resulted in improved outcomes for patients, including higher rates of complete response and disease-free survival. However, the study also noted that the rates of complete response were lower than those reported in previous studies. The researchers are continuing to analyze the data to determine other factors that may contribute to these findings. [Extracted from the article]
Copyright of Gastroenterology Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
New Rectal Cancer Research from National University Cancer Institute Discussed [Total neoadjuvant therapy (TNT) for locally advanced rectal cancer (LARC): Real-world experience from a tertiary Asian cancer center].
|
---|---|
Zeitschrift: | Gastroenterology Week, 2024-02-05, S. 688-688 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1543-6756 (print) |
Schlagwort: |
|
Sonstiges: |
|